Topical Rx Restores Testosterone Levels to Normal in Men

This article originally appeared here.
Share this content:
Topical Rx Restores Testosterone Levels to Normal in Men
Topical Rx Restores Testosterone Levels to Normal in Men

MONDAY, Feb. 22, 2016 (HealthDay News) -- Application of once-daily topical testosterone effectively restores normal testosterone levels in men, according to a study published in the March issue of The Journal of Urology.

Gerald Brock, M.D., from the University of Western Ontario in London, Canada, and colleagues conducted a randomized trial in which testosterone (60 mg topical 2 percent solution) and placebo were compared in 715 adult men with total testosterone less than 300 ng/dL and at least one symptom of testosterone deficiency (decreased energy and/or decreased sexual drive).

The researchers found that testosterone level was within the normal range at study end point in 73 percent of men in the testosterone group versus 15 percent in the placebo group (P < 0.001). Men in the testosterone group showed greater improvement in Sexual Arousal, Interest and Drive scale scores (low sex drive subset P < 0.001 versus placebo) and Hypogonadism Energy Diary scores (low energy subset P = 0.02 versus placebo, not significant at prespecified P < 0.01). There were no major adverse cardiovascular or venous thrombotic events reported in the testosterone group. Increased hematocrit incidence was higher with testosterone versus placebo (P = 0.04).

"Once daily testosterone solution 2 percent for 12 weeks was efficacious in restoring normal testosterone levels and improving sexual drive in hypogonadal men," the authors write.

Several authors disclosed financial ties to Eli Lilly, which administered the trial.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »